Systematic review and meta-analysis of humoral immunity proteins and mortality in sepsis
Antoine Villa(Hôpital Fernand-Widal), Jonas Tverring(Lund University), Emma Rademaker(University Medical Center Utrecht), Tzu Hsuan Cheng(SUNY Downstate Health Sciences University), Morten Hedetoft(University of Copenhagen), Yuxin Mi(Centre for Human Genetics), D. Gilroy(University College London), Mikael Bodelsson(Lund University), G. Monneret(Hospices Civils de Lyon), M. F. Scully(UCL Biomedical Research Centre), E Giamarellos-Bourboulis(National and Kapodistrian University of Athens), Raymond J. Langley(Lovelace Respiratory Research Institute), M. Zhang(SUNY Downstate Health Sciences University), Stephen F. Kingsmore(Children’s Institute), Masayuki Akatsuka(Sapporo Medical University), M.C. de la Torre Terron(Maresme Health Consortium), Julian C. Knight(Centre for Human Genetics), Corina C. Heinz(Biotest (Germany)), Merry L. Lindsey(University of Mississippi Medical Center), Walter Pisciotta(Bury College), Henning Ebelt(Martin Luther University Halle-Wittenberg), Sven A Kerneis(Bury College), Kai Hilpert(St George's, University of London), Fabienne Venet(Université Claude Bernard Lyon 1), Fiona Dewar(Bury College), Gül BATUM(Bury College), Jesús F Bermejo-Martin(Instituto de Investigación Biomédica de Salamanca), Aline de Nooijer(Radboud University Nijmegen), Pietro Caironi(Mario Negri Institute for Pharmacological Research), Tom McDonnell(Centre for Inflammation Research), Dave Brealey(Bury College), Jennifer Meessen(Mario Negri Institute for Pharmacological Research), Mervyn Singer(Bury College), Mihai G. Netea(Radboud University Nijmegen), Timothy D. McHugh(University College London), Ankit Rai(Bury College)
Cited by 1
Related Papers
Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
|New England Journal of Medicine|2012|2.8k
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
|Cell|2021|1.2k
Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial
|The Lancet|2013|940
Antibody evasion by the P.1 strain of SARS-CoV-2
|Cell|2021|661